ALK and non-small cell lung carcinoma: Similarly, patients with specific molecular subtypes of NSCLC have an increased predisposition for brain metastases, such as those with an epidermal growth factor receptor (EGFR) mutation, or anaplastic lymphoma kinase (ALK) rearrangement [22,23,24].